Psychotropes and pregnancy;Psychotropes et grossesse

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 29, Issue SUPPL. 1, 2000, Pages 43-51

  Elefant, E ^a   Bavoux, F ^b   Vauzelle Gardier, C ^a,b   Cournot, M P ^a   Assari Merabtene, F ^a  

^a HÔPITAL SAINT ANTOINE   (France)

^b HÔPITAL SAINT VINCENT DE PAUL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIPARKINSON AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CHLORPROMAZINE; CLOBAZAM; CLOMIPRAMINE; CLONAZEPAM; CLORAZEPATE DIPOTASSIUM; DIAZEPAM; FLUOXETINE; HALOPERIDOL; IMIPRAMINE; MORPHINE DERIVATIVE; NEUROLEPTIC AGENT; NORDAZEPAM; NORFLUOXETINE; NORTRIPTYLINE; OXAZEPAM; PAROXETINE; PETHIDINE; PHENOBARBITAL; PHENYTOIN; PRAZEPAM; PSYCHOTROPIC AGENT; TRIAZOLAM; TRIHEXYPHENIDYL; TROPATEPINE; VALPROIC ACID; VALPROMIDE;

CONFERENCE PAPER; FETOTOXICITY; FETUS RISK; MENTAL PATIENT; PREGNANCY; TERATOGENICITY;

ABNORMALITIES, DRUG-INDUCED; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; BENZODIAZEPINES; FEMALE; FETUS; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS; PSYCHOTROPIC DRUGS; RISK FACTORS;

EID: 0034051614     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (61)

1. Addis D, Koren G. Safety of fluoxetine during the first trimester of pregnancy : meta-analytical review of epidemiological data. Teratology 1997; 55 (1): 100.
2. Aftel RJ, Handel MH. Madness and loss of motherhood : sexuality, reproduction, and long-term mental illness. American Psychiatric Press, Washington, 1993.
3. Allan LD, Desai G, Tynan MJ. Prenatal echocardiographic screening for Ebstein's anomaly for mothers on lithium therapy. Lancet 1982; 16: 875-6.
4. Ananth J. Lithium during pregnancy and lactation. Lithium 1993; 4: 231-7.
5. Bavoux F, Bodiou C, Elefant E. Médicaments du système nerveux central et bébé. Neuropsychiatr Enf 1991 ; 39 : 457-68.
6. Bavoux F, Fournier-Perhilou AI, Wood C, Francoual C, Boccara JF. Neonatal fibrinogen depletion caused by sodium valproate. Ann Pharmacother 1994 ; 28: 1307.
7. Bromiker R, Kaplan M. Apparent intrauterine fetal withdrawal from Clomipramine Hydrochloride. JAMA 1994; 272: 1722-3.
8. Caccia S, Garattini S. Formation of active metabolites of psychotropic drugs. An updated review of their significance. Pharmacokinet 1990 ; 18: 434-59.
9. Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones KL. Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 1996 ; 335 (14): 1010-15.
10. Cleary MF. Fluphenazine decanoate during pregnancy. Am J Psychiatr 1977; 134: 815-6.
11. Cohen LS, Friedman JM, Jefferson JW. et al. A reevaluation of risk in utero to exposure to lithium. JAMA 1994; 271: 146-50.
12. Cornelissen M, Steegers-Theunissen R, Kollée L, Eskes T, Motohara K, Monnens L. Supplementation of vitamin K in pregnant women receiving anticonvulsivant therapy prevents neonatal vitamin K deficiency. Am J Obstet Gynecol 1993; 163: 884-8.
13. Crombie DL, Pinsent RJ, Fleming D. Imipramine in pregnancy (letter). Br Med J 1972; 1: 745.
14. Czeizel A. Diazepam, phenytoin and aetiology of cleft lip and/ or cleft palate. Lancet 1976 ; 1: 810.
15. Delgado-Escueta AV, Janz D. Consensus guidelines : preconception counseling, management, and care of the pregnant woman with epilepsy. Neurology 1992 ; 42: 149-60.
16. Dolovich LR, Addis A, Vaillancourt JMR, Power JDB, Koren G, Einarson TR. Benzodiazepine use in pregnancy and major malformations or oral cleft : meta-analysis of cohort and case-control studies. BMJ 1998; 317: 839-43.
17. Eggermont E. Neonatal effects of maternal therapy with tricyclic antidepressant drug. Arch Dis Child 1980; 55: 81.
18. Elefant E, Boyer P, Roux C. Tératologie. Encycl Med Chir Obstétrique, 5116A10, 3-1986 ; 16p.
19. Elefant E, Bavoux F. Médicaments et grossesse. Dans : Tournaire M. Mises à jour en Gynécologie et Obstétrique, Vigot (éds), 1987 ; pp 287-345.
20. Elia J, Katz IR, Simpson GM. Teratogenicity of psychotherapeutic medications. Psychopharmacol Bull 1987; 23: 531-86.
21. Enns WM, Reiss JP. L'électrochoc. Revue canadienne de psychiatrie 1992 ; 37 : 679-85.
22. Falteman CG, Richardson CJ. Small left colon syndrome associated with maternal ingestion of psychotropic drugs. J Ped 1980; 97: 308-10.
23. Goldstein DJ. Effects of third trimester fluoxetine exposure on the newborn. J Clin Psychopharmacol 1995 ; 15: 417-20.
24. Haeusler MCH, Hoellwarth ME, Holzer D. Paralytic ileus in a fetus-neonate after maternal intake of benzodiazepine. Prenatal Diagnosis 1995 ; 15: 1165-7.
25. Jacobson SJ, Jones K, Johnson K. et al. Prospective multicentre study of pregnancy outcome after lithium exposure during first trimester. Lancet 1992; 339: 530-3.
26. Jick H, Holmes L, Hunter J, Madsen S. et al. First trimester drug use and congenital disorders. JAMA 1981; 246: 343-6.
27. Källen B. Comments on teratogen update : lithium. Teratol 1988; 38: 597.
28. Kanto JH. Use of benzodiazepines during prengnacy, labour and lactation, with particular reference to pharmacokinetic considerations. Drugs 1982; 23: 354-80.
29. Kems LL. Treatment of mental disorders in pregnancy. A review of psychotropic drug risks and benefits. J Nerv Ment Dis 1986; 174 (11): 652-9.
30. Lindhout D, Omtzigt JGC. Teratogenic effects of antiepileptic drugs: implications for the management of epilepsy in women of childbearing age. Epilepsia 1994 ; 35 (4): S19-S28.
31. Krause S, Ebbesen F, Lange AP. Polyhydramnios with maternal lithium treatment. Obstet Gynecol 1990 ; 75: 504.
32. Legius E, Jaeken J, Eggermont E. Sodium valporate, pregnancy, and infantile fatal liver failure. Lancet 1987; 2: 1518-9.
33. Majer RV, Green PJ. Neonatal afibrinogenemia due to sodium valporate. Lancet 1987; 2: 740-1.
34. McBride WG. Limb deformities associated with iminodibenzyl hydrochloride (letter). Med J Aust 1972; 1: 492.
35. Meut C. Grossesse et neuroleptiques : complications néonatales. À propos d'un cas d'entérocolite nécrosante. Thèse de Médecine, Paris VI, 1990.
36. Meut C, Bavoux F, Cynober E, Lebrun F. Necrotizing enterocolitis in a newborn: maternal psychotropic drugs suspected. Can J Psychiatry 1994 ; 39: 127.
37. Mikovitch L Van Den Berg BJ. Effects of prenatal meprobamate and chlordiazepoxide hydrochloride on human embryonic and fetal development N Engl J Med 1974 ; 291: 1268-71.
38. Morrell P, Sutherland GR, Buamath PK. et al. Lithium toxicity in a neonate. Arch Dis Child 1983; 58: 539.
39. Morselli PL. Influence du développement sur la pharmacocinétique des médicaments chez le nouveau-né, le nourrisson et l'enfant. Ann Pédiatr 1986 ; 33 : 151-60.
40. Nation RL. Drug kinetics in childbirth. Clin Pharmacokinet 1980; 5: 340-64.
41. Ostergaard GZ, Pedersen SE. Neonatal effects of maternal clomipramine treatment. Pediatrics 1982 ; 69: 233-4.
42. Pastuszak A, Schick-Boschetto B, Zuber C. et al. Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac). JAMA 1993 ; 169: 2246-8.
43. Platt JE, Friedhoff A, Broman SH. et al. Effects of prenatal neuroleptic drug exposure on motor performance in children. Hum Psychopharmacol 1989; 4: 205-13.
44. Rane A, Tomson G. Prenatal and neonatal metabolism in man. Eur J Clin Pharmacol 1980; 18: 9-15.
45. Robinson GE, Stewart DE, Flak E. The rational use of psychotropic drugs in pregnancy and postpartum. Can J Psychatry1986 ; 31: 183-90.
46. Rosenberg L, Mitchell A, Parsells J, Pashayan HS. et al. Lack of relation of oral cleft to diazepam use during prengancy. N Engl J Med 1983 ; 309: 1282-5.
47. Roux C, Migne G, Mulliez N, Youssef S. Fréquence des malformations à la naissance. Étude d'une maternité parisienne pendant 5 ans. J Gyn Obstet 1982 ; 11 : 215-26.
48. Rumeau-Rouquette C, Goujard J, Huel G. Possible teratogenic effect of phenothiazines in human beings. Teratol 1977; 15: 57-64.
49. Saxen I, Saxen L. Association between maternal intake of diazepam and oral clefts (letter). Lancet 1975; 2: 498.
50. Schimmell MS, Katz EZ, Shaag Y, Pastuszak A, Koren G. Toxic neonatal effects following maternal clomipramine therapy. Clinical Toxicology 1991; 29: 479-84.
51. Schou M, Amdisen A, Eskjaer SJ. et al. Occurrence of goitre during lithium treatment. Br Med J 1968; 3: 710-3.
52. Schou M, Goldfield MD, Weinstein MR. et al. Lithium and pregnancy - I. report from the register of lithium babies. BMJ 1973; 2: 135-6.
53. Schou M. What happened later to the lithium babies? A follow-up study of children born without malformations. Acta Psychatr Scand 1976; 54: 193-7.
54. Schou M. Lithium treatment during pregnancy, delivery, and lactation: an update. J Clin Psychatry 1990; 51: 410-3.
55. Spencer MJ. Fluoxetine hydrochloride (Prozac) toxicity in a neonate. Pediatrics 1990; 92: 721-2.
56. Stanford MS, Patton JH. In utero exposure to fluoxetine HCI increases hematoma frequency at birth. Pharmacology Biochemist and Behaviour, 1993; 45: 959-62.
57. Tamer A, McKey R, Arias D. et al. Phenothiazine-induced extrapyramidal dysfunction in the neonate. J Pediatr 1969; 75: 479-80.
58. Vanelle JM, Bouvet O, Brochier P, Allouche G, Rouillon F, Lôo H. Place de l'échotrochocthérapie dans les troubles psychiatriques de la puerpéralité. Annales médico-psychologiques 1991 ; 149 : 265-9.
59. Vorhees CV, Brunner RL, Butcher RE. Psychotropic drugs as behavioral teratogens. Science 1979; 205: 1220-5.
60. Weinstein MR. The international register of lithium babies. Drug information J 1976; 2: 94-100.
61. Wilson N, Forfar JC, Godman MJ. A trial flutter in the newborn resulting from maternal lithium ingestion. Arch Dis Child 1983; 58: 538-49.